|
US20050019325A1
(en)
|
1996-01-08 |
2005-01-27 |
Carter Paul J. |
WSX receptor agonist antibodies
|
|
US7074397B1
(en)
|
1996-01-08 |
2006-07-11 |
Genentech, Inc. |
Method for enhancing proliferation or differentiation of a cell using ob protein
|
|
EP1619250B1
(en)
*
|
1996-01-08 |
2009-11-25 |
Genentech, Inc. |
OB receptor variant and ligands
|
|
US6541604B1
(en)
|
1996-01-08 |
2003-04-01 |
Genentech, Inc. |
Leptin receptor having a WSX motif
|
|
US7063958B1
(en)
*
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
|
AU725133B2
(en)
|
1997-01-15 |
2000-10-05 |
Polaris Group |
Modified tumor necrosis factor
|
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
|
SG2008070138A
(en)
|
1998-10-16 |
2017-08-30 |
Biogen Ma Inc |
Polymer conjugates of interferon beta- 1a and their uses
|
|
EA005005B1
(en)
|
1998-10-16 |
2004-10-28 |
Байоджен, Инк. |
HUMAN INTERFERON beta-1alpha HYBRID POLYPEPTIDE, MUTANTS THEREOF AND DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF
|
|
US7297511B2
(en)
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
|
US7226903B2
(en)
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
ES2466024T3
(en)
|
2001-10-10 |
2014-06-09 |
Ratiopharm Gmbh |
Remodeling and glycoconjugation of fibroblast growth factor (FGF)
|
|
US7473680B2
(en)
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
|
DE10209821A1
(en)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Coupling of proteins to a modified polysaccharide
|
|
BR0314107A
(en)
*
|
2002-09-11 |
2005-07-19 |
Fresenius Kabi De Gmbh |
Production method of hydroxyalkyl starch derivatives
|
|
AU2003273413A1
(en)
|
2002-10-08 |
2004-05-04 |
Fresenius Kabi Deutschland Gmbh |
Pharmaceutically active oligosaccharide conjugates
|
|
CN1809378B
(en)
|
2002-11-18 |
2010-06-23 |
德西涅Rx制药公司 |
method for inhibiting viral replication in vivo
|
|
NZ542094A
(en)
|
2003-03-14 |
2008-12-24 |
Neose Technologies Inc |
Branched polymer conjugates comprising a peptide and water-soluble polymer chains
|
|
US20070026485A1
(en)
|
2003-04-09 |
2007-02-01 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRACELLULAR FORMATION OF PEPTIDE CONJUGATES
|
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
|
EP1694347B1
(en)
|
2003-11-24 |
2013-11-20 |
BioGeneriX AG |
Glycopegylated erythropoietin
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
JP2007515410A
(en)
*
|
2003-12-03 |
2007-06-14 |
ネオス テクノロジーズ インコーポレイテッド |
GlycoPEGylated follicle stimulating hormone
|
|
WO2005070138A2
(en)
|
2004-01-08 |
2005-08-04 |
Neose Technologies, Inc. |
O-linked glycosylation of peptides
|
|
ES2339953T5
(en)
|
2004-05-04 |
2020-05-06 |
Novo Nordisk Healthcare Ag |
O-linked factor VII glycoforms and method of manufacture
|
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
|
US8268967B2
(en)
|
2004-09-10 |
2012-09-18 |
Novo Nordisk A/S |
Glycopegylated interferon α
|
|
ES2566670T3
(en)
|
2004-10-29 |
2016-04-14 |
Ratiopharm Gmbh |
Remodeling and glucopegilation of fibroblast growth factor (FGF)
|
|
JP4951527B2
(en)
|
2005-01-10 |
2012-06-13 |
バイオジェネリックス アーゲー |
GlycoPEGylated granulocyte colony stimulating factor
|
|
US20070154992A1
(en)
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
EP2975135A1
(en)
|
2005-05-25 |
2016-01-20 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
|
US7985839B2
(en)
|
2006-03-31 |
2011-07-26 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
|
US7982010B2
(en)
|
2006-03-31 |
2011-07-19 |
Baxter International Inc. |
Factor VIII polymer conjugates
|
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
|
NZ572050A
(en)
|
2006-03-31 |
2011-09-30 |
Baxter Int |
Factor VIII conjugated to polyethylene glycol
|
|
US20080248959A1
(en)
|
2006-07-21 |
2008-10-09 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
|
EP2054521A4
(en)
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
|
|
AU2007333049B2
(en)
|
2006-12-15 |
2014-02-20 |
Takeda Pharmaceutical Company Limited |
Factor VIIa-(poly)sialic acid conjugate having prolonged in vivo half-life
|
|
PL2144923T3
(en)
|
2007-04-03 |
2013-12-31 |
Biogenerix Ag |
Methods of treatment using glycopegylated g-csf
|
|
EP2170919B8
(en)
|
2007-06-12 |
2016-01-20 |
ratiopharm GmbH |
Improved process for the production of nucleotide sugars
|
|
EP2197919B1
(en)
|
2007-08-27 |
2014-04-09 |
ratiopharm GmbH |
Liquid formulation of g-csf conjugate
|
|
KR20180041269A
(en)
|
2008-01-22 |
2018-04-23 |
아라임 파마슈티칼즈, 인크. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
EP2626079A3
(en)
|
2008-02-27 |
2014-03-05 |
Novo Nordisk A/S |
Conjungated factor VIII molecules
|
|
DK2279405T3
(en)
|
2008-05-13 |
2014-01-13 |
Advanced Liquid Logic Inc |
Drip actuator devices, systems and methods
|
|
US9795683B2
(en)
|
2009-07-27 |
2017-10-24 |
Lipoxen Technologies Limited |
Glycopolysialylation of non-blood coagulation proteins
|
|
KR101832937B1
(en)
|
2009-07-27 |
2018-02-28 |
박스알타 인코퍼레이티드 |
Blood coagulation protein conjugates
|
|
US8809501B2
(en)
|
2009-07-27 |
2014-08-19 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
|
HUE028056T2
(en)
|
2009-07-27 |
2016-11-28 |
Baxalta GmbH |
Blood coagulation protein conjugates
|
|
US8642737B2
(en)
|
2010-07-26 |
2014-02-04 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
|
HUE049352T2
(en)
|
2010-12-22 |
2020-09-28 |
Baxalta GmbH |
Materials and methods for conjugating a water soluble fatty acid derivative to a protein
|
|
BR112014025737A2
(en)
|
2012-04-16 |
2017-07-04 |
Cantab Biopharmaceuticals Patents Ltd |
method for administering a therapeutic agent, method for preventing entry of a therapeutic agent, method for modulating the rate of release of a therapeutic agent, therapeutic agent, dosage forms, method of treating a disease and parts kit
|
|
EP3448415A4
(en)
|
2016-04-29 |
2019-11-06 |
Araim Pharmaceuticals, Inc. |
TISSUE PROTECTIVE PEPTIDES FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE INJURY
|